Caffeine to improve neurodevelopmental outcomes in infants born late preterm (The Latte Trial): study protocol for a randomised controlled trial.
Trials2025Canning JM, McKinlay CJD, McNamara DG, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
Age FactorsCaffeineCentral Nervous System StimulantsChild DevelopmentCitratesCognitionDouble-Blind MethodEquivalence Trials as TopicFemaleGestational AgeHumansInfantInfant, NewbornInfant, PrematureMaleMulticenter Studies as TopicNew ZealandRandomized Controlled Trials as TopicResearch DesignTime FactorsTreatment Outcome
DOI 10.1186/s13063-025-09029-9
PMID 40993821
原文・出典を見る →